Agreements & Collaborations Were the Most-preferred Strategy Followed by Key Players in the Vaccine Adjuvants Market
The vaccine adjuvants market is consolidated in nature due to the presence of a few large players. Prominent players in the vaccine adjuvants market include Brenntag Biosector (Denmark), CSL Limited (Australia), SEPPIC (France), Agenus, Inc. (U.S.), Novavax, Inc. (U.S.), SPI Pharma, Inc. (U.S.), Invivogen (U.S.), Avanti Polar Lipids, Inc. (U.S.), MVP Laboratories, Inc., and OZ Biosciences (France). Get Research Insights @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=152603894 Brenntag Biosector (Denmark) was the global leader in the vaccine adjuvants market in 2015. The company is a subsidiary of Brenntag AG (Germany). It is a well-known company and has an exhaustive product portfolio. The company is innovation-centric and invests heavily in R&D for maintaining its market share. The company also focuses on inorganic growth strategies such as agreements to enhance its market share. For instance, Brenntag Biosector A/S (Denmark) signed an agreement w...